DD216017A5 - Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a - Google Patents

Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a Download PDF

Info

Publication number
DD216017A5
DD216017A5 DD83256672A DD25667283A DD216017A5 DD 216017 A5 DD216017 A5 DD 216017A5 DD 83256672 A DD83256672 A DD 83256672A DD 25667283 A DD25667283 A DD 25667283A DD 216017 A5 DD216017 A5 DD 216017A5
Authority
DD
German Democratic Republic
Prior art keywords
aza
epi
deoxo
desoxo
homoerythromycin
Prior art date
Application number
DD83256672A
Other languages
German (de)
English (en)
Inventor
Gene M Bright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD216017A5 publication Critical patent/DD216017A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DD83256672A 1982-11-15 1983-11-14 Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a DD216017A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15

Publications (1)

Publication Number Publication Date
DD216017A5 true DD216017A5 (de) 1984-11-28

Family

ID=23755068

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83256672A DD216017A5 (de) 1982-11-15 1983-11-14 Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a

Country Status (26)

Country Link
EP (1) EP0109253B1 (ja)
JP (1) JPS59104398A (ja)
KR (1) KR850000968B1 (ja)
AT (1) ATE30237T1 (ja)
AU (1) AU544790B2 (ja)
CA (1) CA1239639A (ja)
CS (1) CS241069B2 (ja)
DD (1) DD216017A5 (ja)
DE (1) DE3374065D1 (ja)
DK (1) DK159322C (ja)
EG (1) EG16641A (ja)
ES (2) ES8600327A1 (ja)
FI (1) FI72980C (ja)
GR (1) GR79425B (ja)
GT (1) GT198304062A (ja)
HU (1) HU193886B (ja)
IE (1) IE56234B1 (ja)
IL (1) IL70228A (ja)
NO (1) NO160262C (ja)
NZ (1) NZ206259A (ja)
PH (2) PH19293A (ja)
PL (2) PL142601B1 (ja)
PT (1) PT77645B (ja)
SU (1) SU1272996A3 (ja)
YU (2) YU43198B (ja)
ZA (1) ZA838460B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
CA2068951A1 (en) * 1991-05-20 1992-11-21 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
MX9605419A (es) * 1994-05-06 1997-12-31 Pfizer Formas de dosificacion de liberacion controlada de azitromicina.
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DK1206476T3 (da) * 1999-08-24 2006-05-15 Abbott Lab 9a-azalider med antibakteriel virkning
WO2001049697A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
JP2004506664A (ja) 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513145A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
PL244557A1 (en) 1985-03-26
ES8604257A1 (es) 1986-01-16
NO834146L (no) 1984-05-16
FI72980B (fi) 1987-04-30
PH21560A (en) 1987-12-11
ES527249A0 (es) 1985-10-01
DK159322B (da) 1990-10-01
KR840006673A (ko) 1984-12-01
AU544790B2 (en) 1985-06-13
IL70228A (en) 1987-03-31
EG16641A (en) 1990-08-30
YU224383A (en) 1986-04-30
DK518683D0 (da) 1983-11-14
PL142601B1 (en) 1987-11-30
DK159322C (da) 1991-02-25
PT77645A (en) 1983-12-01
IE56234B1 (en) 1991-05-22
IL70228A0 (en) 1984-02-29
FI834163A (fi) 1984-05-16
EP0109253A3 (en) 1984-09-12
HU193886B (en) 1987-12-28
JPS59104398A (ja) 1984-06-16
SU1272996A3 (ru) 1986-11-23
NO160262C (no) 1989-03-29
YU43425B (en) 1989-06-30
ZA838460B (en) 1985-06-26
IE832652L (en) 1984-05-15
NO160262B (no) 1988-12-19
CA1239639A (en) 1988-07-26
PH19293A (en) 1986-03-04
CS241069B2 (en) 1986-03-13
GT198304062A (es) 1985-05-04
PL250350A1 (en) 1985-04-24
GR79425B (ja) 1984-10-22
JPH0140038B2 (ja) 1989-08-24
DK518683A (da) 1984-05-16
NZ206259A (en) 1986-08-08
FI834163A0 (fi) 1983-11-14
ES8600327A1 (es) 1985-10-01
CS845583A2 (en) 1985-07-16
PT77645B (en) 1986-05-12
FI72980C (fi) 1987-08-10
YU43198B (en) 1989-04-30
YU197285A (en) 1986-08-31
EP0109253B1 (en) 1987-10-14
ES543638A0 (es) 1986-01-16
PL143281B1 (en) 1988-01-30
ATE30237T1 (de) 1987-10-15
HUT35273A (en) 1985-06-28
AU2130983A (en) 1984-05-24
DE3374065D1 (en) 1987-11-19
KR850000968B1 (ko) 1985-07-02
EP0109253A2 (en) 1984-05-23

Similar Documents

Publication Publication Date Title
DD216017A5 (de) Verfahren zur herstellung von 4"-epi-9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
DE2618822C3 (de) Anthracyclin-Glycoside und Verfahren zu deren Herstellung
US4526889A (en) Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPH01193292A (ja) Ｎ−メチル１１−アザ−１０−デオキソ−１０−ジヒドロエリスロマイシンａ製造用中間体
DE2346535B2 (de) Verfahren zur Herstellung von 7-Dimethylamino-e-desmethyl-e-desoxytetracyclin über 9-tert.Butyl-6-desmethyl-6-desoxytetracyclin
DE2411504C3 (de) 6'-Substituierte 6'-Desoxylividomycine B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD211565A5 (de) Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel
US5023240A (en) Derivatives of tylosin and 10,11,12,13-tetrahydro tylosin and their use in pharmaceuticals
DE2831579C3 (de) Tetrahydropyranylether von Daunomycin und Adriamycin, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
CH636869A5 (en) Process for the preparation of flavones
EP0136831A2 (en) Azahomoerythromycin B derivatives and intermediates thereof
DE2366288C3 (de) Verfahren zur Herstellung von 3' -Desoxykanamycin B und 3' -Desoxyneamin
DE2804507C2 (de) 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel
DE2731306C3 (de) 9-Desacetyl- und 9-Desacetyl-9-epi-daunorubicin, Verfahren zu deren Herstellung und deren Verwendung
DE2756057A1 (de) Verfahren zur herstellung von 3',4'-dideoxykanamycin b
DE3227178C2 (de) 2'-Modifizierte Kanamycine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
CH642973A5 (de) Antitumoranthracycline mit verzweigtkettigen aminodeoxyzuckerresten.
DE69418715T2 (de) Erythromycinderivate
DE3641835A1 (de) Zytostatisch wirksame anthracyclinderivate
DE3009910C2 (de) 3',4'-Diepi-4'-O-methyl-daunorubicin und -doxorubicin, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CH642975A5 (de) 4''-deoxy-4''-glyoxamido- und -carbonylthioformamidoderivate von oleandomycin und dessen estern, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
CA1250284A (en) Antibacterial epimeric azahomoerythromycin a derivative and production thereof
DE69200900T2 (de) 1,5-Diyn-3-cycloalkenderivate, ihr Herstellungsverfahren und diese enthaltende pharmazeutische Compositionen.
AT360159B (de) Verfahren zur herstellung von neuen 4''-amino- -oleandomycinen
DE2633913A1 (de) 6'-hydroxyderivate von antitumoranthracyclinen

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee